Safety and efficacy of sodium-glucose co-transporter-2 inhibitors and aldosterone inhibitors combinations in chronic kidney disease: A systematic review and meta-analysis Ahmed W. Hageen, Reem Sayad, Alyaa Khaled Abdelmonem, Katia Latifa, Lina Musallam, Moustafa Abouelkheir, Sherif Mira, Ahmed Awad, Ahmed Afsa, Waleed Nassar, Gehad El Ashal, Mohamed Elmasry, Eshak I. Bahbah

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, Roberto Alcázar, Nicolás Manito, Manuel Botana